Hypersensitivity reactions to deoxycoformycin

Peter J. O'Dwyer, Susan A. King, Elizabeth Eisenhauer, Jean L Grem, Daniel F. Hoth

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Deoxycoformycin (dCF) is a promising new antineoplastic agent in the treatment of lymphoid malignancies, particularly hairy cell leukemia (HCL). Skin toxicity in the form of a maculopapular eruption has previously been reported but has not clearly been associated with idiosyncratic reactions. We present five cases of dCF-related hypersensitivity reactions in which additional systemic manifestations indicated an allergic etiology. The value of dCF in treating lymphoid neoplasms suggests that further study of the treatment of these reactions is indicated.

Original languageEnglish (US)
Pages (from-to)173-175
Number of pages3
JournalCancer Chemotherapy and Pharmacology
Volume23
Issue number3
DOIs
StatePublished - Mar 1 1989

Fingerprint

Pentostatin
Hypersensitivity
Hairy Cell Leukemia
Antineoplastic Agents
Toxicity
Neoplasms
Skin

ASJC Scopus subject areas

  • Oncology
  • Toxicology
  • Pharmacology
  • Cancer Research
  • Pharmacology (medical)

Cite this

O'Dwyer, P. J., King, S. A., Eisenhauer, E., Grem, J. L., & Hoth, D. F. (1989). Hypersensitivity reactions to deoxycoformycin. Cancer Chemotherapy and Pharmacology, 23(3), 173-175. https://doi.org/10.1007/BF00267950

Hypersensitivity reactions to deoxycoformycin. / O'Dwyer, Peter J.; King, Susan A.; Eisenhauer, Elizabeth; Grem, Jean L; Hoth, Daniel F.

In: Cancer Chemotherapy and Pharmacology, Vol. 23, No. 3, 01.03.1989, p. 173-175.

Research output: Contribution to journalArticle

O'Dwyer, PJ, King, SA, Eisenhauer, E, Grem, JL & Hoth, DF 1989, 'Hypersensitivity reactions to deoxycoformycin', Cancer Chemotherapy and Pharmacology, vol. 23, no. 3, pp. 173-175. https://doi.org/10.1007/BF00267950
O'Dwyer, Peter J. ; King, Susan A. ; Eisenhauer, Elizabeth ; Grem, Jean L ; Hoth, Daniel F. / Hypersensitivity reactions to deoxycoformycin. In: Cancer Chemotherapy and Pharmacology. 1989 ; Vol. 23, No. 3. pp. 173-175.
@article{983d8c11169742048dc11153f206820d,
title = "Hypersensitivity reactions to deoxycoformycin",
abstract = "Deoxycoformycin (dCF) is a promising new antineoplastic agent in the treatment of lymphoid malignancies, particularly hairy cell leukemia (HCL). Skin toxicity in the form of a maculopapular eruption has previously been reported but has not clearly been associated with idiosyncratic reactions. We present five cases of dCF-related hypersensitivity reactions in which additional systemic manifestations indicated an allergic etiology. The value of dCF in treating lymphoid neoplasms suggests that further study of the treatment of these reactions is indicated.",
author = "O'Dwyer, {Peter J.} and King, {Susan A.} and Elizabeth Eisenhauer and Grem, {Jean L} and Hoth, {Daniel F.}",
year = "1989",
month = "3",
day = "1",
doi = "10.1007/BF00267950",
language = "English (US)",
volume = "23",
pages = "173--175",
journal = "Cancer Chemotherapy and Pharmacology",
issn = "0344-5704",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - Hypersensitivity reactions to deoxycoformycin

AU - O'Dwyer, Peter J.

AU - King, Susan A.

AU - Eisenhauer, Elizabeth

AU - Grem, Jean L

AU - Hoth, Daniel F.

PY - 1989/3/1

Y1 - 1989/3/1

N2 - Deoxycoformycin (dCF) is a promising new antineoplastic agent in the treatment of lymphoid malignancies, particularly hairy cell leukemia (HCL). Skin toxicity in the form of a maculopapular eruption has previously been reported but has not clearly been associated with idiosyncratic reactions. We present five cases of dCF-related hypersensitivity reactions in which additional systemic manifestations indicated an allergic etiology. The value of dCF in treating lymphoid neoplasms suggests that further study of the treatment of these reactions is indicated.

AB - Deoxycoformycin (dCF) is a promising new antineoplastic agent in the treatment of lymphoid malignancies, particularly hairy cell leukemia (HCL). Skin toxicity in the form of a maculopapular eruption has previously been reported but has not clearly been associated with idiosyncratic reactions. We present five cases of dCF-related hypersensitivity reactions in which additional systemic manifestations indicated an allergic etiology. The value of dCF in treating lymphoid neoplasms suggests that further study of the treatment of these reactions is indicated.

UR - http://www.scopus.com/inward/record.url?scp=0024520529&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024520529&partnerID=8YFLogxK

U2 - 10.1007/BF00267950

DO - 10.1007/BF00267950

M3 - Article

VL - 23

SP - 173

EP - 175

JO - Cancer Chemotherapy and Pharmacology

JF - Cancer Chemotherapy and Pharmacology

SN - 0344-5704

IS - 3

ER -